Transforming Growth Factor-β1 Polymorphisms and Graft-versus-host Disease Risk: a Meta-analysis

Overview

Journal Oncotarget

Specialty Oncology

Date 2015 Nov 7

PMID 26544732

Citations 2

Authors

Lin Zhang

Lihong Mao

Junxiu Xu

Affiliations

Soon will be listed here.

Abstract

Some studies have demonstrated that transforming growth factor (TGF)-β polymorphisms may have an important role in the pathological process of graft-versus-host disease (GVHD). However, the results are not consistent. Thus, we performed a meta-analysis. Online databases were searched to obtain relevant articles published up until May 2015. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of associations. Donors (OR=0.56; 95%CI, 0.32-0.98; P=0.04) and recipients (OR=0.73; 95%CI, 0.63-0.85; P<0.0001) with TGF-β1 rs1800469 polymorphism showed decreased GVHD risk, respectively. Donors with TGF-β1 rs1800470 polymorphism were also observed to have lower GVHD risk (OR=0.65; 95%CI, 0.46-0.94; P=0.02). However, TGF-β1 rs1800470 polymorphism in recipients was not associated with GVHD risk (OR=1.28; 95%CI, 0.81-2.01; P=0.29). No significant heterogeneity was found in the meta-analysis. This meta-analysis suggests that donors or recipients with TGF-β1 rs1800469 polymorphism and donors with TGF-β1 rs1800470 polymorphism might be associated with reduced GVHD risk.

Citing Articles

Investigation of TGFB1 -1347C>T variant as a biomarker after allogeneic hematopoietic stem cell transplantation.

Kovy P, Meggyesi N, Varga L, Balassa K, Bors A, Gopcsa L Bone Marrow Transplant. 2019; 55(1):215-223.

PMID: 31527815 DOI: 10.1038/s41409-019-0656-4.

Polymorphisms in the TGFB1 and IL2RA genes are associated with clinical forms of leprosy in Brazilian population.

Camargo R, Silva W, Medeiros P, Belone A, Latini A Mem Inst Oswaldo Cruz. 2018; 113(12):e180274.

PMID: 30540075 PMC: 6287188. DOI: 10.1590/0074-02760180274.

References

Li Q, Zhai Z, Xu X, Shen Y, Zhang A, Sun Z . Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation. Leuk Res. 2010; 34(9):1158-68. DOI: 10.1016/j.leukres.2010.03.017. View

Karimi M, Daneshmandi S, Pourfathollah A, Geramizadeh B, Ramzi M, Yaghobi R . The IFN-gamma allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplant. Exp Clin Transplant. 2010; 8(2):125-9. View

Pooja S, Francis A, Rajender S, Tamang R, Rajkumar R, Saini K . Strong impact of TGF-β1 gene polymorphisms on breast cancer risk in Indian women: a case-control and population-based study. PLoS One. 2013; 8(10):e75979. PMC: 3798290. DOI: 10.1371/journal.pone.0075979. View

Kim D, Won H, Su S, Cheng L, Xu W, Hamad N . Risk stratification of organ-specific GVHD can be improved by single-nucleotide polymorphism-based risk models. Bone Marrow Transplant. 2014; 49(5):649-56. DOI: 10.1038/bmt.2014.20. View

Hill G, Ferrara J . The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood. 2000; 95(9):2754-9. View

Holweg C, Baan C, Balk A, Niesters H, Maat A, Mulder P . The transforming growth factor-beta1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation. Transplantation. 2001; 71(10):1463-7. DOI: 10.1097/00007890-200105270-00018. View

Verrecchia F, Mauviel A . Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol. 2002; 118(2):211-5. DOI: 10.1046/j.1523-1747.2002.01641.x. View

Gorelik L, Flavell R . Transforming growth factor-beta in T-cell biology. Nat Rev Immunol. 2002; 2(1):46-53. DOI: 10.1038/nri704. View

Zheng S, Wang J, Koss M, Quismorio Jr F, Gray J, Horwitz D . CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J Immunol. 2004; 172(3):1531-9. DOI: 10.4049/jimmunol.172.3.1531. View

10.

Grainger D, Heathcote K, Chiano M, Snieder H, Kemp P, Metcalfe J . Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet. 1999; 8(1):93-7. DOI: 10.1093/hmg/8.1.93. View

11.

Visentainer J, Lieber S, Persoli L, Marques S, Vigorito A, Aranha F . Relationship between cytokine gene polymorphisms and graft-versus-host disease after allogeneic stem cell transplantation in a Brazilian population. Cytokine. 2005; 32(3-4):171-7. DOI: 10.1016/j.cyto.2005.09.002. View

12.

Appelbaum F . Hematopoietic-cell transplantation at 50. N Engl J Med. 2007; 357(15):1472-5. DOI: 10.1056/NEJMp078166. View

13.

Jacobsohn D, Vogelsang G . Acute graft versus host disease. Orphanet J Rare Dis. 2007; 2:35. PMC: 2018687. DOI: 10.1186/1750-1172-2-35. View

14.

Noori-Daloii M, Rashidi-Nezhad A, Izadi P, Hossein-Nezhad A, Sobhani M, Derakhshandeh-Peykar P . Transforming growth factor-beta1 codon 10 polymorphism is associated with acute GVHD after allogenic BMT in Iranian population. Ann Transplant. 2008; 12(4):5-10. View

15.

Ogawa S, Matsubara A, Onizuka M, Kashiwase K, Sanada M, Kato M . Exploration of the genetic basis of GVHD by genetic association studies. Biol Blood Marrow Transplant. 2009; 15(1 Suppl):39-41. DOI: 10.1016/j.bbmt.2008.11.020. View

16.

Shah R, Selby S, Yokley B, Slack R, Hurley C, Posch P . TNF, LTA and TGFB1 genotype distributions among acute graft-vs-host disease subsets after HLA-matched unrelated hematopoietic stem cell transplantation: a pilot study. Tissue Antigens. 2009; 74(1):50-6. PMC: 3215084. DOI: 10.1111/j.1399-0039.2009.01257.x. View

17.

Berro M, Mayor N, Maldonado-Torres H, Cooke L, Kusminsky G, Marsh S . Association of functional polymorphisms of the transforming growth factor B1 gene with survival and graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation. Haematologica. 2009; 95(2):276-83. PMC: 2817031. DOI: 10.3324/haematol.2009.010835. View

18.

Rashidi-Nezhad A, Azimi C, Alimoghaddam K, Ghavamzadeh A, Hossein-Nezhad A, Izadi P . TGF-Beta codon 25 polymorphism and the risk of graft-versus-host disease after allogenic hematopoietic stem cell transplantation. Iran J Allergy Asthma Immunol. 2010; 9(1):1-6. DOI: 09.01/ijaai.16. View

19.

Xiao H, Cao W, Lai X, Luo Y, Shi J, Tan Y . Immunosuppressive cytokine gene polymorphisms and outcome after related and unrelated hematopoietic cell transplantation in a chinese population. Biol Blood Marrow Transplant. 2010; 17(4):542-9. DOI: 10.1016/j.bbmt.2010.04.013. View